Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
复制标题
在临床肠杆菌中具有碳青霉烯酶活性的新型 GES/IBC 广谱 β-内酰胺酶变体。
DOI:
10.1111/j.1574-6968.2004.tb09535.x
复制
发表时间:
2004
影响因子:
2.1
通讯作者:
L. Tzouvelekis
中科院分区:
文献类型:
--
作者:
S. Vourli;P. Giakkoupi;V. Miriagou;E. Tzelepi;A. Vatopoulos;L. Tzouvelekis
Two clinical isolates, an Escherichia coli and a Klebsiella pneumoniae, with decreased susceptibility to carbapenems were studied. This phenotype was associated with production of novel GES/IBC variant beta-lactamases, designated GES-3 (from E. coli) and GES-4 (from K. pneumoniae), exhibiting carbapenemase activity. Both enzymes possessed Ser at Ambler's position 170 instead of Gly found in the beta-lactamases GES-1 and IBC-1 that lack carbapenemase activity. Additionally, position 104 in GES-4 was occupied by a Lys as in IBC-1. bla(GES-3) and bla(GES-4) occurred as gene cassettes in the variable regions of class 1 integrons carried by plasmids. The structure of the GES-4-encoding integron was similar to that of previously described IBC-1 integrons. The GES-3-encoding integron was, most likely, truncated at the 3' conserved segment.